Search results for "viral"

showing 10 items of 2737 documents

Genotyping of bovine diarrhea virus (BVDV) isolated from cattle in Sicily

2011

Bovine Viral Diarrhoea - Mucosal Disease (BVD-MD) is a widely spread infectious disease that cause economically important losses in farms. Several epidemiological studies indicate a high genetic heterogeneity among Bovine Viral Diarrhoea Virus (BVDV) strains circulating in Italy. The aim of this study was to investigate the genotypes of BVDV in Sicily, a region in the South of Italy. For this purpose, 17 BVDV strains collected from cattle breed in Sicily between 2005 and 2008 were genetically typed by sequencing of 5'-untraslated region (5’-UTR) of the viral genome. In this study, phylogenetic analysis showed that all 17 examined strains were clustered within the BVDV genotype 1. Particular…

genetic characterizationPhylogenetic analysiBovine Viral Diarrhoea Virus (BVDV)molecular epidemiology
researchProduct

The Social Life of Viruses

2021

Despite their simplicity, viruses exhibit certain types of social interactions. Situations in which a given virus achieves higher fitness in combination with other members of the viral population have been described at the level of transmission, replication, suppression of host immune responses, and host killing, enabling the evolution of viral cooperation. Although cellular coinfection with multiple viral particles is the typical playground for these interactions, cooperation between viruses infecting different cells is also established through cellular and viral-encoded communication systems. In general, the stability of cooperation is compromised by cheater genotypes, as best exemplified…

genetic structuresGenotypeSpatial structurevirusesPopulationVirus-virus interactionsSuperinfection exclusionBiologyVirus ReplicationVirus03 medical and health sciencesVirologymedicineDefective interfering particleseducationViral evolution030304 developmental biology0303 health scienceseducation.field_of_studySocial evolution030306 microbiologyTransmission (medicine)Host (biology)Virionmedicine.diseaseCooperationEvolutionary biologyViral evolutionVirusesCoinfectionSocial evolutionAnnual Review of Virology
researchProduct

Imūnā atbildes reakcija uz vakcināciju pret vīrushepatītu B hemodialīzes pacientiem

2018

Pamatojums: Hemodialīzes (HD) pacientiem ir paaugstināts ar asinīm pārnesamām infekciju risks, piemēram, vīrushepatīta B infekcija (HBV). Pacientiem ar terminālu nieru mazspēju bieži ir imūnsistēmas nomākums, kas rezultējās ar nepietiekamu imūnās atbildes reakciju pret HBV vakcināciju. Adekvāta imunoloģiska atbilde it tad, ja anti-HBs-antivielu titrs >10 mSV/ml. Lai gan atbildes reakcija vispārējā populācijā ir aptuveni 95%, HD pacientiem tā ir robežās no 50-80%. Mērķis: noteikt HBV infekcijas izplatību, identificēt imūno atbildes reakciju HD pacientiem uz HBV vakcināciju un izvērtēt tās ietekmējošus klīniskus un laboratoriskus faktorus. Materiāli un metodes: Tika analizēta HBV izplatība HD…

hemodialysisviral hepatitis Bvaccinationimmune responseMedicīna
researchProduct

Grazoprevir/elbasvir for the immediate treatment of recently acquired HCV genotype 1 or 4 infection in MSM.

2020

Abstract Background In Europe, increases in HCV infection have been observed over the last two decades in MSM, making them a key population for recently acquired HCV. Alternative combinations of direct-acting antiviral agents against early HCV infection need to be assessed. Patients and methods In this pilot trial, MSM with recently acquired genotype 1 or 4 HCV infection were prospectively included and received 8 weeks of oral grazoprevir 100 mg and elbasvir 50 mg in a fixed-dose combination administered once daily. The primary endpoint was sustained virological response evaluated 12 weeks after the end of treatment (EOT) (SVR12). Secondary endpoints were the virological characterization of…

hepatitis C virusCyclopropanesMaleadverse eventmen who have sex with menHepacivirusmedicine.disease_causeSexual and Gender Minoritiesblood HIV RNA0302 clinical medicine[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesfollow-upClinical endpointMedicinePharmacology (medical)infections030212 general & internal medicinehepatitis ceducation.field_of_studySulfonamideshepatitis c rnaImidazolesvirus diseasesHepatitis Cvirologyhepatitis C virus genotype 13. Good healthEuropeInfectious DiseasesGrazoprevirRNA Viral030211 gastroenterology & hepatologyDrug Therapy CombinationMicrobiology (medical)medicine.medical_specialtyElbasvirGenotypeHepatitis C virusPopulationelbasvirAntiviral Agentsreinfection03 medical and health sciencesInternal medicineQuinoxalinesHumansHomosexuality MaleAdverse effecteducationplasmasuicideBenzofuransPharmacologybusiness.industrySurrogate endpointHIVgrazoprevirHepatitis C Chronicmedicine.diseaseAmidessurrogate endpoints[SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/PharmacologyQuality of LifeCarbamatesbusinessThe Journal of antimicrobial chemotherapy
researchProduct

Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe

2018

All-oral direct-acting antiviral drugs (DAAs) for hepatitis C virus, which have response rates of 95% or more, represent a major clinical advance. However, the high list price of DAAs has led many governments to restrict their reimbursement. We reviewed the availability of, and national criteria for, interferon-free DAA reimbursement among countries in the European Union and European Economic Area, and Switzerland. Reimbursement documentation was reviewed between Nov 18, 2016, and Aug 1, 2017. Primary outcomes were fibrosis stage, drug or alcohol use, prescriber type, and HIV co-infection restrictions. Among the 35 European countries and jurisdictions included, the most commonly reimbursed …

hepatitis C virusHIV Infectionschemistry.chemical_compound0302 clinical medicineAntiviral Agents/economicsHIV-HCV co-infection030212 general & internal medicineReimbursementliver fibrosismedia_commonDasabuvirCoinfectionHealth PolicyGastroenterologyHepatitis C3. Good healthEuropeHepatitis C Chronic/complicationsInsurance Health Reimbursement030211 gastroenterology & hepatologySwitzerlandmedicine.drugmedicine.medical_specialtyHIV Infections/complicationsAntiviral AgentsDrug Costs03 medical and health scienceshepatitis C treatmentmedicineHumansmedia_common.cataloged_instanceEuropean UnionEuropean unionPWIDIntensive care medicineHepatitisdirect-acting antiviralHepatologybusiness.industryHepatitis C Chronicalcohol usemedicine.diseasereimbursementVirologyOmbitasvirchemistryParitaprevirRitonavirbusinesstreatment restrictionsThe Lancet Gastroenterology & Hepatology
researchProduct

Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1b

2021

HCV is an important cause of hepatocellular carcinoma (HCC). HCV NS5A domain-1 interacts with cellular proteins inducing pro-oncogenic pathways. Thus, we explore genetic variations in NS5A domain-1 and their association with HCC, by analyzing 188 NS5A sequences from HCV genotype-1b infected DAA-naïve cirrhotic patients: 34 with HCC and 154 without HCC. Specific NS5A mutations significantly correlate with HCC: S3T (8.8% vs. 1.3%, p = 0.01), T122M (8.8% vs. 0.0%, p &lt

hepatitis C virusLiver CirrhosisMaleCirrhosisvirusesHepacivirusViral Nonstructural ProteinsNS5Amedicine.disease_causeSeverity of Illness Indexgenetic variabilityMedicineLiver Neoplasmsvirus diseaseshepatocellular carcinomaMiddle AgedHepatitis CQR1-502Infectious DiseasesHepatocellular carcinomaHCVHost-Pathogen InteractionsFemaleDisease SusceptibilityCarcinoma HepatocellularGenotypeHepatitis C virusViremiaMicrobiologyArticleStructure-Activity RelationshipVirologyGenetic variationHumansGenetic variabilityNS5AneoplasmsAgedbusiness.industrycirrhosisSequence Analysis DNAbiochemical phenomena metabolism and nutritiongenotype 1bmedicine.diseaseSettore MED/17digestive system diseasesMutationCancer researchbusinessCarcinogenesisBiomarkersViruses
researchProduct

Modeling cost-effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real-life cohort

2017

We evaluated the cost-effectiveness of two alternative direct-acting antiviral (DAA) treatment policies in a real-life cohort of hepatitis C virus–infected patients: policy 1, “universal,” treat all patients, regardless of fibrosis stage; policy 2, treat only “prioritized” patients, delay treatment of the remaining patients until reaching stage F3. A liver disease progression Markov model, which used a lifetime horizon and health care system perspective, was applied to the PITER cohort (representative of Italian hepatitis C virus–infected patients in care). Specifically, 8,125 patients naive to DAA treatment, without clinical, sociodemographic, or insurance restrictions, were us…

hepatitis C virusPediatricsCost effectivenessViral HepatitisAdult; Aged; Aged 80 and over; Antiviral Agents; Cohort Studies; Cost-Benefit Analysis; Health Policy; Hepatitis C; Humans; Middle Aged; Young Adult; Models Economic; HepatologyCost-Benefit AnalysisDirect-acting antiviralAdult; Aged; Aged 80 and over; Antiviral Agents; Cohort Studies; Cost-Benefit Analysis; Health Policy; Hepatitis C; Humans; Middle Aged; Young Adult; Models EconomicCohort StudiesLiver disease0302 clinical medicineModelsHealth careantiviral therapy80 and overincremental cost-effectiveness ratiohealth care economics and organizationsHCV cost -effectivenessAged 80 and overDirect-acting antiviral hepatocellular carcinoma hepatitis C virus incremental cost-effectiveness ratio interferon quality-adjusted life-years sustained virological response willingness to payCost–benefit analysis030503 health policy & servicesquality-adjusted life-yearsHealth PolicyHepatitis Chepatocellular carcinomainterferonMiddle AgedHepatitis CModels EconomicAdult; Aged; Aged 80 and over; Antiviral Agents; Cohort Studies; Cost-Benefit Analysis; Health Policy; Hepatitis C; Humans; Middle Aged; Young Adult; Models Economic; Hepatology; HCV; antiviral therapy; cost-effectiveness; real-life cohortCohortHCV030211 gastroenterology & hepatologyOriginal Articlesustained virological response0305 other medical scienceCohort studyHumanAdultmedicine.medical_specialtyEconomicAntiviral AgentsNO03 medical and health sciencesYoung Adultreal-life cohortmedicineHumansCost-Benefit Analysicost-effectivenessHealth policyAgedAntiviral AgentHepatologybusiness.industryOriginal Articlesmedicine.diseaseSurgeryCohort Studiebusinesswillingness to pay
researchProduct

Evolución post-trasplante hepático de los pacientes con cirrosis por VHC y coinfectados por VIH. Comparación con pacientes monoinfectados por VHC

2020

La infección por el virus de la inmunodeficiencia humana (VIH) ha experimentado progresos importantes en las últimas décadas gracias a la aparición de terapias antirretrovirales potentes y eficaces, lo que ha permitido controlar el desarrollo de infecciones oportunistas y aumentar la supervivencia de estos pacientes. Así, las enfermedades hepáticas son una de las causas principales de morbimortalidad en los pacientes VIH, que frecuentemente presentan confección con virus hepatotropos como el virus de la hepatitis B (VHB) y el virus de la hepatitis C (VHC). La causa más frecuente de enfermedad hepática en pacientes VIH en nuestro medio es la confección con el VHC, que además presenta un curs…

hepatitis c recurrentetrasplante hepáticoUNESCO::CIENCIAS MÉDICAS ::Ciencias clínicas::Patología clínicaagentes antivirales directosconfección VIH/VHC:CIENCIAS MÉDICAS ::Ciencias clínicas::Patología clínica [UNESCO]
researchProduct

Practices in research, surveillance and control of neglected tropical diseases by One Health approaches: A survey targeting scientists from French-sp…

2021

One health (OH) approaches have increasingly been used in the last decade in the fight against zoonotic neglected tropical diseases (NTDs). However, descriptions of such collaborations between the human, animal and environmental health sectors are still limited for French-speaking tropical countries. The objective of the current survey was to explore the diversity of OH experiences applied to research, surveillance and control of NTDs by scientists from French-speaking countries, and discuss their constraints and benefits. Six zoonotic NTDs were targeted: echinococcoses, trypanosomiases, leishmaniases, rabies, Taenia solium cysticercosis and leptospiroses. Invitations to fill in an online q…

http://aims.fao.org/aos/agrovoc/c_8081RC955-962Psychological interventionSocial Scienceshttp://aims.fao.org/aos/agrovoc/c_431Computer-assisted web interviewingPolitical Aspects of HealthGlobal HealthSanté publique0302 clinical medicineMedical ConditionsArctic medicine. Tropical medicineSurveys and QuestionnairesPublic and Occupational Healthhttp://aims.fao.org/aos/agrovoc/c_6970media_commonMammalsSanté animaleNeglected DiseasesEukaryota3. Good healthÉpidémiologie[SDV] Life Sciences [q-bio]http://aims.fao.org/aos/agrovoc/c_1790medicine.drug_formulation_ingredientOne Healthhttp://aims.fao.org/aos/agrovoc/c_2085Veterinary Diseases[SDE]Environmental SciencesPublic aspects of medicinehttp://aims.fao.org/aos/agrovoc/c_4027http://aims.fao.org/aos/agrovoc/c_8068http://aims.fao.org/aos/agrovoc/c_8500medicine.medical_specialtyRabiesmedia_common.quotation_subjectPolitical ScienceLeptospiroseRage03 medical and health sciencesPolitical scienceTaenia soliumhttp://aims.fao.org/aos/agrovoc/c_3081HumansSurveillance épidémiologiquehttp://aims.fao.org/aos/agrovoc/c_8530Survey ResearchPublic Health Environmental and Occupational HealthOrganismsBiology and Life SciencesTropical Diseaseshttp://aims.fao.org/aos/agrovoc/c_7558http://aims.fao.org/aos/agrovoc/c_6349http://aims.fao.org/aos/agrovoc/c_4281Veterinary ScienceDiversity (politics)[SDE] Environmental SciencesViral DiseasesBiomedical Researchhttp://aims.fao.org/aos/agrovoc/c_2615[SDV]Life Sciences [q-bio]http://aims.fao.org/aos/agrovoc/c_870SurveysL73 - Maladies des animauxhttp://aims.fao.org/aos/agrovoc/c_875http://aims.fao.org/aos/agrovoc/c_16411http://aims.fao.org/aos/agrovoc/c_7988http://aims.fao.org/aos/agrovoc/c_6416ZoonosesTrypanosomoseMedicine and Health Sciences030212 general & internal medicinehttp://aims.fao.org/aos/agrovoc/c_3423http://aims.fao.org/aos/agrovoc/c_5164http://aims.fao.org/aos/agrovoc/c_4510http://aims.fao.org/aos/agrovoc/c_16415EchinococcoseInfectious DiseasesResearch DesignS50 - Santé humaineVertebrateshttp://aims.fao.org/aos/agrovoc/c_7979Neglected tropical diseasesRA1-1270Zone tropicaleResearch ArticleNeglected Tropical Diseaseszoonosehttp://aims.fao.org/aos/agrovoc/c_28665030231 tropical medicineMEDLINEResearch and Analysis Methodshttp://aims.fao.org/aos/agrovoc/c_259http://aims.fao.org/aos/agrovoc/c_35197DogsEnvironmental healthTropical MedicinemedicineLeishmanioseAnimalsCysticercosehttp://aims.fao.org/aos/agrovoc/c_5181Enquête pathologique[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieTropical medicineAmniotes[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieZoology
researchProduct

Recurrent domestication by Lepidoptera of genes from their parasites mediated by Bracoviruses

2015

Bracoviruses are symbiotic viruses associated with tens of thousands of species of parasitic wasps that develop within the body of lepidopteran hosts and that collectively parasitize caterpillars of virtually every lepidopteran species. Viral particles are produced in the wasp ovaries and injected into host larvae with the wasp eggs. Once in the host body, the viral DNA circles enclosed in the particles integrate into lepidopteran host cell DNA. Here we show that bracovirus DNA sequences have been inserted repeatedly into lepidopteran genomes, indicating this viral DNA can also enter germline cells. The original mode of Horizontal Gene Transfer (HGT) unveiled here is based on the integrativ…

hôteanimal structuresBase Sequenceadn virallcsh:QH426-470Biodiversité et EcologieMolecular Sequence DataWaspsinsecte parasitefungiGenes InsectvirusSpodopterabracovirusBiodiversity and Ecologylcsh:GeneticsPolydnaviridaeDNA ViralAnimalsguêpelepidoptera[SDE.BE]Environmental Sciences/Biodiversity and Ecologygénomique des populationsResearch Article
researchProduct